Cost-effectiveness of pharmacist-led care versus usual care in type 2 diabetic Jordanians: a Markov modeling of cardiovascular diseases prevention

References

• World Health Organisation. Cardiovascular disease: overview; 2020 [cited 2020 Jun 6]. Available from: https://www.who.int/health-topics/cardiovascular-diseases/#tab=tab_1
   Google Scholar
• Einarson TR, Acs A, Ludwig C, et al. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health. 2018 Jul;21(7):881–890.
   PubMed Web of Science ®Google Scholar
• Reynolds R, Dennis S, Hasan I, et al. A systematic review of chronic disease management interventions in primary care. BMC Fam Pract. 2018;19(1):11.
   PubMedGoogle Scholar
• Sullivan J, Jett BP, Cradick M, et al. Effect of clinical pharmacist intervention on hemoglobin A1C reduction in veteran patients with type 2 diabetes in a rural setting. Ann Pharmacother. 2016 Dec;50(12):1023–1027.
   PubMed Web of Science ®Google Scholar
• Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008 Apr;28(4):421–436.
   PubMed Web of Science ®Google Scholar
• Acs A, Ludwig C, Bereza BG, et al. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health. 2017;20(9):A476–A477.
   Web of Science ®Google Scholar
• Ourth H, Nelson J, Spoutz P, et al. Development of a pharmacoeconomic model to demonstrate the effect of clinical pharmacist involvement in diabetes management. J Manag Care Spec Pharm. 2018 May;24(5):449–457.
   PubMed Web of Science ®Google Scholar
• Fera T, Bluml BM, Ellis WM. Diabetes ten city challenge: final economic and clinical results. J Am Pharm Assoc (2003). 2009 May-Jun;49(3):383–391.
   PubMed Web of Science ®Google Scholar
• Siaw MYL, Malone DC, Ko Y, et al. Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: short-term results from a randomized controlled trial. J Clin Pharm Ther. 2018 Dec;43(6):775–783.
   PubMed Web of Science ®Google Scholar
• Jamshed SQ, Siddiqui MJ, Rana B, et al. Evaluation of the involvement of pharmacists in diabetes self-care: a review from the economic perspective. Front Public Health. 2018;6:244.
   PubMed Web of Science ®Google Scholar
• Yu J, Shah BM, Ip EJ, et al. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser permanente northern California. JMCP. 2013 Mar;19(2):102–114.
   PubMed Web of Science ®Google Scholar
• Hirsch JD, Bounthavong M, Arjmand A, et al. Estimated Cost-effectiveness, cost benefit, and risk reduction associated with an endocrinologist-pharmacist diabetes intense medical management “tune-up” clinic. J Manag Care Spec Pharm. 2017 Mar;23(3):318–326.
   PubMed Web of Science ®Google Scholar
• The World Bank. The world bank in Jordan; 2018 [cited 2020 Nov 27]. Available from: http://www.worldbank.org/en/country/jordan/overview
   Google Scholar
• Jordan High Health Council. The national strategy for health sector in Jordan; 2019 [cited 2018 Jan 16]. Available from: http://www.hhc.gov.jo/uploadedimages/The%20National%20Strategy%20for%20Health%20Sector%20in%20Jordan%202015-2019.pdf
   Google Scholar
• Hammad EA, Qudah RA, Akour AA. The impact of clinical pharmacists in improving Jordanian patients’ health outcomes. Saudi Med J. 2017 Nov;38(11):1077–1089.
   PubMed Web of Science ®Google Scholar
• Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin sci. 2001 Dec;101(6):671–679.
   PubMed Web of Science ®Google Scholar
• Jarab AS, Alqudah SG, Mukattash TL, et al. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. JMCP. 2012 Sep;18(7):516–526.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Life tables by country: Jordan; 2017 [cited 2019 Apr 21]. Available from: http://apps.who.int/gho/data/?theme=main&vid=60830
   Google Scholar
• Dababneh F, Nichols EK, Asad M, et al. Improving mortality data in Jordan: a 10 year review. Bull World Health Organ. 2015 Oct 1;93(10):727–731.
   PubMed Web of Science ®Google Scholar
• Statista. Jordan: age structure from 2006 to 2016; 2018 [cited 2019 Jan 25]. Available from: https://www.statista.com/statistics/385468/age-structure-in-jordan/
   Google Scholar
• Abi Khalil C, Al Suwaidi J, Refaat M, et al. Cardiac complications of diabetes. Biomed Res Int. 2018;2018:8578394.
   PubMed Web of Science ®Google Scholar
• Aksnes TA, Kjeldsen SE, Rostrup M, et al. Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: the Valsartan Antihypertensive long-term use evaluation (VALUE) trial. Blood Press. 2016 Aug;25(4):235–240.
   PubMed Web of Science ®Google Scholar
• Fu G-R, Yuan W-Q, Du W-L, et al. Risk factors associated with recurrent strokes in young and elderly patients: a hospital-based study. Int J Gerontol. 2015;9(2):63–66.
   Web of Science ®Google Scholar
• Ajlouni K, Khader YS, Batieha A, et al. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complications. 2008 Sep-Oct;22(5):317–324.
   PubMed Web of Science ®Google Scholar
• Rr Hr T, Khader Y, Hammoudeh AJ. Smoking cessation in the middle east after percutaneous coronary intervention. Results from the first Jordanian percutaneous coronary intervention registry (JoPCR1). World J Cardiovasc Dis. 2016;6(7):202.
   Google Scholar
• Al-Eitan LN, Nassar AM, Dajani RB, et al. Diabetes mellitus in two genetically distinct populations in Jordan. A comparison between Arabs and Circassians/Chechens living with diabetes. Saudi Med J. 2017 Feb;38(2):163–169.
   PubMed Web of Science ®Google Scholar
• Sarapultsev P, Yushkov B, Sarapultsev A. Prevalence of arrhythmias in patients with type 2 diabetes and the role of structural changes in myocardium in their development. Diabetes Metab Syndr. 2017 Dec;11(Suppl 2):S567–S576.
   PubMedGoogle Scholar
• Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care. 2009 Oct;32(10):1851–1856.
   PubMed Web of Science ®Google Scholar
• Central Bank of Jordan. Monetary policy interest rates; 2019 [cited 2019 May 20]. Available from: http://www.cbj.gov.jo/Pages/viewpage.aspx?pageID=230
   Google Scholar
• World Health Organization B, Rob M. P. M, Adam, Taghreed, Tan-Torres Edejer, Tessa, Hutubessy, Raymond C. W. et al. Making choices in health: WHO guide to cost-effectiveness analysis; 2003 [2019 May 21]. Available from: http://www.who.int/iris/handle/10665/42699
   Google Scholar
• Bertram MY, Lauer JA, De Joncheere K, et al. Cost-effectiveness thresholds: pros and cons. Bull World Health Organ. 2016 Dec 1;94(12):925–930.
   PubMed Web of Science ®Google Scholar
• Hutubessy R, Chisholm D, Edejer TT. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc. 2003 Dec 19;1(1):8.
   PubMedGoogle Scholar
• Woods B, Revill P, Sculpher M, et al. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. 2016 Dec;19(8):929–935.
   PubMed Web of Science ®Google Scholar
• Al Mazroui NR, Kamal MM, Ghabash NM, et al. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol. 2009 May;67(5):547–557.
   PubMed Web of Science ®Google Scholar
• Robberstad B. QALYs vs DALYs vs LYs gained: what are the differences, and what difference do they make for health care priority setting? Norsk Epidemiologi. 2009;15(2):183–191.
   Google Scholar
• Wang K, Gong M, Xie S, et al. Nomogram prediction for the 3-year risk of type 2 diabetes in healthy mainland China residents. EPMA Journal. 2019 2019/09/01;10(3):227–237.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shao Y, Shi W-Q, et al. The predictive potential of altered spontaneous brain activity patterns in diabetic retinopathy and nephropathy. EPMA Journal. 2019 Sept 1;10(3):249–259.
   PubMed Web of Science ®Google Scholar
• Golubnitschaja O, Baban B, Boniolo G, et al. Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016. Epma J. 2016;7(1):23.
   PubMedGoogle Scholar
• Golubnitschaja O, Kinkorova J, Costigliola V. Predictive, preventive and personalised medicine as the hardcore of ‘horizon 2020ʹ: EPMA position paper. Epma J. 2014 April 07;5(1):6.
   PubMedGoogle Scholar
• Nijpels G, Beulens JWJ, van der Heijden AAWA, et al. Innovations in personalised diabetes care and risk management. Eur J Prev Cardiol. 2019 Dec 01;26(2_suppl):125–132.
   PubMed Web of Science ®Google Scholar
• Barrett M, Boyne J, Brandts J, et al. Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care. Epma J. 2019 Dec;10(4):445–464.
   PubMed Web of Science ®Google Scholar
• Duarte AA, Mohsin S, Golubnitschaja O. Diabetes care in figures: current pitfalls and future scenario. Epma J. 2018 Jun;9(2):125–131.
   PubMed Web of Science ®Google Scholar
• Wilson PW, Meigs JB, Sullivan L, et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham offspring study. Arch Intern Med. 2007 May 28;167(10):1068–1074.
   PubMed Web of Science ®Google Scholar
• Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003 Mar;26(3):725–731.
   PubMed Web of Science ®Google Scholar
• Chung SM, Park JC, Moon JS, et al. Novel nomogram for screening the risk of developing diabetes in a Korean population. Diabetes Res Clin Pract. 2018 Aug;142:286–293.
   PubMed Web of Science ®Google Scholar